A High-Margin Rural and Remote Health Growth Story Taking Shape

For investors who care about real-world impact as much as upside, Rocket Doctor AI (OTCQB: AIRDF) (CSE: AIDR) is starting to look interesting. 2025 was the company’s first true “business year” after acquiring the original Rocket Doctor digital health platform and marketplace, and the FY 2025 numbers now tell a clear story: this is an early‑stage, high‑risk opportunity, but it’s also a real operating business with growing revenue, very high margins, and a clear focus on virtual and rural care.

Here’s what retail investors should know.

First Revenues, and Growing

Until 2025, Rocket Doctor AI was essentially a story stock: a public vehicle with AI ambition but not much revenue. That changed when it acquired Rocket Doctor Inc., a physician‑founded digital health platform and marketplace focused on delivering quality care to patients in underserved and rural communities. Rocket Doctor accomplishes the mission by providing the tools for established doctors to run their own virtual care business, kind of a ‘Shopify for physicians’ concept.

That acquisition closed in April 2025, and you can see the financial impact immediately. In the second quarter of 2025, the company reported about C$0.5 million in revenue, its first meaningful revenue quarter. That top line came from virtual visits and platform services flowing through the newly acquired business.

By year‑end, management was highlighting multiple revenue streams: virtual care contracts with U.S. health plans, technology fees, and early revenue from a medical education product built on its AI engine. For a company that only a year earlier was effectively pre‑commercial, that’s a big shift.

High Gross Margins

One of the most important numbers in the 2025 results is gross margin. In Q2 2025, Rocket Doctor AI reported gross margin of roughly 89%; Q3 checked in with 88% gross margin; and Q4 with 84%. That’s not a typo, but reflective of the low operating costs associated with a software-heavy platform business.

Like most early‑stage growth names, Rocket Doctor AI is still investing heavily in product, sales, and market expansion. The company is especially invested in expansion across key markets in the United States. While the vast majority of 2025 revenue was from the company’s Canadian business, where they’ve helped over 750,000 patients to date, the growth story lies in its fledgling U.S. business.

Since launching in the States, Rocket Doctor AI has announced a string of agreements with insurers (programs including commercial, Medicaid, Medicare, and Veterans) across California, New York, and Maryland. Altogether, Rocket Doctor AI is now an approved in-network provider for over 21 million covered patients in the United States. The growth curve for the market is potentially steep, and the company is focused in turning those agreements into revenue in 2026.

Investor Keys

If you’re looking for a mature, dividend‑paying healthcare name, this is not it. This is a growth‑stage platform betting on a future where more care is delivered virtually, more clinicians work in hybrid setups, and rural patients don’t have to drive hours just to see a doctor.

For retail investors who like early‑stage healthcare growth stories with real‑world impact, Rocket Doctor AI now has enough on the board to be evaluated seriously:

• Revenue is no longer hypothetical; it’s real and growing.
• Gross margins are high, typical of a scalable software and marketplace model.
• The company has concrete U.S. contracts, not just slide‑deck partnerships.

If you’re bullish on AI, virtual and rural care, and you’re looking for a small‑cap that’s actually shipping products, signing payers, and working with real physicians instead of just talking about AI, Rocket Doctor AI is now firmly in that conversation.

Sponsored Content Disclosure: This article is sponsored by Rocket Doctor AI. SECFilings.com has partnered with the company to help share its story with a broader audience of investors and industry followers. SECFilings.com is being compensated $15,000 USD per quarter by 45 Degrees Inc. While we strive to present accurate information and maintain editorial standards, this content is part of a paid awareness initiative. Please do your own research and consult a licensed advisor before making investment decisions.